Exercise
ProcedureSubjects will be given and individualized exercise program.
NCT Number: NCT02444273
The primary outcome of this study is to demonstrate the feasibility of a prehabilitation program at Barnes Jewish Hospital for liver transplant candidates. Those patients who consent to participate in the study and are placed on the transplant list will be randomized into either the control or intervention group. The intervention group receives a personalized home exercise program along with weekly phone calls to provide coaching, mentoring and motivation. Data collected at baseline, post-transplant and, post-transplant follow up will be compared among the two study groups. The secondary outcomes include: normative data of functional measures for patients with end stage liver disease and to determine the effect size for future research on prehabilitation in the patient population.
Looking for future studies?
Notify Me18 year–99 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects will be given and individualized exercise program.
Time frame: 2 Years
Feasibility will be measured by participation and outcome assessment measures.
Time frame: Baseline
Time frame: Baseline
Time frame: Baseline
Time frame: Baseline
Time frame: Baseline
Washington University School of Medicine
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03584646
Atrophy, Behavior
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT03089840
Digestive System Diseases, End Stage Liver Disease
Edmonton, Alberta, Canada
View Trial DetailsNCT01619475
Blood-Borne Infections, Communicable Diseases
San Francisco, California, United States
View Trial DetailsNCT04496479
Digestive System Diseases, End Stage Liver Disease
Boston, Massachusetts, United States
View Trial Details